Putting businesses that are improving health outcomes, at the heart of health and care



The programme
Our aim is to improve health outcomes for everyone.
The Health Matters programme does this by supporting local businesses, with innovative solutions, to access the health and care markets.
By providing bespoke, one-on-one assistance, we help businesses hone their products and services. Through real-world validation we demonstrate their practical and commercial benefits.
Product journey
Where are you on your product development journey? Here at Health Matters, we understand that there are various milestones along the path to creating a new product of service. The journey below maps out some of the common steps – click the one that most closely matches your current challenge and find out how we can help you.

Ideas
Got an innovative idea that could improve health outcomes?

Intellectual
property
Do you need help protecting your idea?

Market analysis
Do you need to know more about your market?

Access to finance
Do you need help raising investment or accessing funding?

Prototype
development
Are you unsure how best to develop your product?

Impact testing
Do you need to find a site to test your prototype?

Independent
evaluation
Do you need support with statistical analysis?

Real world
validation
Do you need to build a business case with positive & tangible health outcomes?

Procurement
Do you want your product to be adopted into the NHS or health and care markets?
Partners
Health Matters is embedded in the NHS, with access to health academic experts and relevant business support services






News
Read local, regional and national news stories relevant to your business here
AHSN Network delivers almost £500m in economic growth
The Innovation Agency and our fellow 14 Academic Health Science Networks (AHSNs) have generated...
Evaluating your innovation
Evaluating your innovation is a new online course to support your journey through evaluating...
New chief exec for Innovation Agency
The Innovation Agency has appointed Dr Phil Jennings as chief executive, four years after he...